In most cases, some people tend to excel in at least one subject. On the other hand, there are people that seem to excel in multiple subjects. Dr. Clay Siegall personifies this notion perfectly as he has earned many different titles throughout his professional career. This doctor’s ambition for fighting cancer is very profound. Between the ages of 19 – 24, his father suffered with this dangerous disease. During this time, Siegall became aware of the limited tools that were available for fighting cancer. For some patients, surgeries and amputation were the only options. After his father’s passing, Siegall started to build his legacy by pursuing a career in cancer research. “I spent many years working in Bristol Myers Squibb’s Pharmaceutical Research Institute,” stated Siegall. Siegall also stated that “I earned a doctorate in genetics from George Washington University.”
As of today, he is the captain of the ship at Bothell, Washington’s Seattle Genetics. Seattle Genetics is a top cancer research company the commercializes and develops targeted-cancer therapies. The company came into fruition back in 1998, and it has been going strong ever since. Seattle Genetics has a huge database/pipeline of medications that will be released in future years. As of now, the company’s ADCETRIS medication is a top choice thanks to its brilliant way of fighting cancer. ADCETRIS received FDA-approval back in 2011 and Dr. Siegall has been able to offer the medications to a worldwide audience. Thanks to his business-sense of getting licensing deals, ADCETRIS is now being distributed by many of today’s top drug companies such as Pfizer, Genentech, Bayer and GlaxoSmithKline.
Dr. Siegall’s passion for helping others can’t be questioned and can’t be disputed. He’s a natural-born philanthropist that truly wants to make a difference. All in all, Dr. Clay Siegall of Seattle Genetics is the ultimate double-edged sword.